{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:07:15Z","timestamp":1791493635246,"version":"4.3.4"},"reference-count":56,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016190","name":"Trond Mohn stiftelse","doi-asserted-by":"publisher","award":["TMS2022STG01"],"award-info":[{"award-number":["TMS2022STG01"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["#21 0401 FE, 21 1749Pj"],"award-info":[{"award-number":["#21 0401 FE, 21 1749Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["#24 3780 Pj"],"award-info":[{"award-number":["#24 3780 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Selanders Stiftelse","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["#2021-02693"],"award-info":[{"award-number":["#2021-02693"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["#2022-01151"],"award-info":[{"award-number":["#2022-01151"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016669","name":"Sj\u00f6bergstiftelsen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100016669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer- and Allergifonden","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,8,1]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>T-cell activation and clonal expansion are essential to effective immunotherapy responses in non-small cell lung cancer (NSCLC). The distribution of T-cell clones may offer insights into immunogenic mechanisms and imply potential prognostic and predictive information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed \u03b1\/\u03b2 T-cell receptor (TCR) clonality using RNA-sequencing of bulk frozen tumor tissue from 182 patients with NSCLC. The data was integrated with molecular and clinical characteristics, extensive in situ imaging, and spatial sequencing of the tumor immune microenvironment. TCR clonality was also determined in an independent cohort of nine patients with immune checkpoint-treated NSCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TCR clonality (Gini index) patterns ranged from high T-cell clone diversity with high evenness (low Gini index) to clonal dominance with low evenness (high Gini index). Generally, TCR clonality in cancer was lower than in matched normal lung parenchyma distant from the tumor (p=0.021). The TCR clonality distribution between adenocarcinoma and squamous cell carcinoma was similar; however, smokers showed a higher Gini index. While in the operated patient with NSCLC cohort, TCR clonality was not prognostic, in an immune checkpoint inhibitor-treated cohort, high TCR clonality was associated with better therapy response (p=0.016) and prolonged survival (p=0.003, median survival 13.8 vs 2.9 months). On the genomic level, a higher Gini index correlated strongly with a lower frequency of epidermal growth factor receptor (EGFR) and adenomatous polypsis coli (APC) gene mutations, but a higher frequency of P53 mutations, and a higher tumor mutation burden. In-depth characterization of the tumor tissue revealed that high TCR clonality was associated with an activated, inflamed tumor phenotype (PRF1, GZMA, GZMB, INFG) with exhaustion signatures (LAG3, TIGIT, IDO1, PD-1, PD-L1). Correspondingly, PD-1+, CD3+, CD8A+, CD163+, and CD138+immune cells infiltrated cancer tissue with high TCR clonality. In situ sequencing recovered single dominant T-cell clones within the patient tumor tissue, which were predominantly of the CD8 subtype and localized closer to tumor cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our robust analysis pipeline characterized diverse TCR repertoires linked to distinct genotypes and immunologic tumor phenotypes. The spatial clustering of expanded T-cell clones and their association with immunological activation underscores a functional, clinically relevant immune response, particularly in patients with NSCLC treated with checkpoint inhibitors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012089","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:20:42Z","timestamp":1756315242000},"page":"e012089","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0563-3243","authenticated-orcid":false,"given":"Hui","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Magoulopoulou","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Stockholm County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Marie","family":"Amini","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paraskevi","family":"Chatzinikolaou","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Stockholm County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Horie","sequence":"additional","affiliation":[{"name":"Division of Molecular and Genomic Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Lindberg","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Mezheyeuski","sequence":"additional","affiliation":[{"name":"Molecular Oncology Group, Vall d\u2019Hebron Institute of Oncology, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Backman","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Metousis","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Stockholm County, Sweden"},{"name":"Dept. of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Brunnstr\u00f6m","sequence":"additional","affiliation":[{"name":"Division of Pathology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millaray","family":"Marincevic","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Botling","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Sofia Margareta","family":"Mattsson","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klas","family":"K\u00e4rre","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Stockholm County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leandersson","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Stockholm County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Strell","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"},{"name":"Center for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-5961","authenticated-orcid":false,"given":"Patrick","family":"Micke","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Uppsala County, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2026052108403430000_13.8.e012089.1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010833","article-title":"Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care","volume":"13","author":"Topalian","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026052108403430000_13.8.e012089.2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010674","article-title":"Determinants of 5-year survival in patients with advanced NSCLC with PD-L1\u226550% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry","volume":"13","author":"Cortellini","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026052108403430000_13.8.e012089.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3245"},{"key":"2026052108403430000_13.8.e012089.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.12.022"},{"key":"2026052108403430000_13.8.e012089.5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005025","article-title":"Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer","volume":"10","author":"Henick","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026052108403430000_13.8.e012089.6","doi-asserted-by":"crossref","unstructured":"Backman M , Strell C , Lindberg A , et al . n.d. Spatial Immunophenotyping of the Tumor Microenvironment in Non-Small Cell Lung Cancer. SSRN Journal. doi:10.2139\/ssrn.4191805","DOI":"10.2139\/ssrn.4191805"},{"key":"2026052108403430000_13.8.e012089.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00984-x"},{"key":"2026052108403430000_13.8.e012089.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00565-9"},{"key":"2026052108403430000_13.8.e012089.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6"},{"key":"2026052108403430000_13.8.e012089.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.03.002"},{"key":"2026052108403430000_13.8.e012089.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.01.016"},{"key":"2026052108403430000_13.8.e012089.12","doi-asserted-by":"publisher","DOI":"10.1002\/path.5772"},{"key":"2026052108403430000_13.8.e012089.13","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2022-0327-OA"},{"key":"2026052108403430000_13.8.e012089.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.027"},{"key":"2026052108403430000_13.8.e012089.15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73639"},{"key":"2026052108403430000_13.8.e012089.16","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0001"},{"key":"2026052108403430000_13.8.e012089.17","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0605"},{"key":"2026052108403430000_13.8.e012089.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0203-y"},{"key":"2026052108403430000_13.8.e012089.19","doi-asserted-by":"publisher","DOI":"10.1038\/nri778"},{"key":"2026052108403430000_13.8.e012089.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2020.07.010"},{"key":"2026052108403430000_13.8.e012089.21","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbx111"},{"key":"2026052108403430000_13.8.e012089.22","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.05.008"},{"key":"2026052108403430000_13.8.e012089.23","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12061389","article-title":"LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients","volume":"12","author":"Paulsen","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026052108403430000_13.8.e012089.24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.807696","article-title":"Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis","volume":"13","author":"Aoki","year":"2022","journal-title":"Front Immunol"},{"key":"2026052108403430000_13.8.e012089.25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14273-0","article-title":"Comprehensive T cell repertoire characterization of non-small cell lung cancer","volume":"11","author":"Reuben","year":"2020","journal-title":"Nat Commun"},{"key":"2026052108403430000_13.8.e012089.26","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-016-0175-4","article-title":"TCR diversity - a universal cancer immunotherapy biomarker?","volume":"4","author":"McNeel","year":"2016","journal-title":"J Immunother Cancer"},{"key":"2026052108403430000_13.8.e012089.27","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954"},{"key":"2026052108403430000_13.8.e012089.28","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0226"},{"key":"2026052108403430000_13.8.e012089.29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24343-x","article-title":"The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival","volume":"12","author":"Valpione","year":"2021","journal-title":"Nat Commun"},{"key":"2026052108403430000_13.8.e012089.30","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3364"},{"key":"2026052108403430000_13.8.e012089.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12896-017-0379-9","article-title":"Overview of methodologies for T-cell receptor repertoire analysis","volume":"17","author":"Rosati","year":"2017","journal-title":"BMC Biotechnol"},{"key":"2026052108403430000_13.8.e012089.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.04.022"},{"key":"2026052108403430000_13.8.e012089.33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1016","article-title":"Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer","volume":"15","author":"Naulaerts","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026052108403430000_13.8.e012089.34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41525-019-0084-9","article-title":"RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia\/lymphoma","volume":"4","author":"Farmanbar","year":"2019","journal-title":"npj Genom Med"},{"key":"2026052108403430000_13.8.e012089.35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86837","article-title":"Profiling cancer testis antigens in non-small-cell lung cancer","volume":"1","author":"Djureinovic","year":"2016","journal-title":"JCI Insight"},{"key":"2026052108403430000_13.8.e012089.36","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00493-8"},{"key":"2026052108403430000_13.8.e012089.37","doi-asserted-by":"publisher","DOI":"10.1002\/path.5026"},{"key":"2026052108403430000_13.8.e012089.38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104452","article-title":"An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers","volume":"88","author":"Mezheyeuski","year":"2023","journal-title":"EBioMedicine"},{"key":"2026052108403430000_13.8.e012089.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.01.003"},{"key":"2026052108403430000_13.8.e012089.40","doi-asserted-by":"crossref","DOI":"10.1242\/dev.202448","article-title":"Open-source, high-throughput targeted in situ transcriptomics for developmental and tissue biology","volume":"151","author":"Lee","year":"2024","journal-title":"Development"},{"key":"2026052108403430000_13.8.e012089.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11534-9"},{"key":"2026052108403430000_13.8.e012089.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-025-02236-5","article-title":"A comprehensive evaluation of diversity measures for TCR repertoire profiling","volume":"23","author":"Mika","year":"2025","journal-title":"BMC Biol"},{"key":"2026052108403430000_13.8.e012089.43","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318"},{"key":"2026052108403430000_13.8.e012089.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0221-9"},{"key":"2026052108403430000_13.8.e012089.45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002780","article-title":"Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer","volume":"9","author":"Kim","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026052108403430000_13.8.e012089.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00562-5"},{"key":"2026052108403430000_13.8.e012089.47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2931"},{"key":"2026052108403430000_13.8.e012089.48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1200"},{"key":"2026052108403430000_13.8.e012089.49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008950","article-title":"High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC","volume":"12","author":"Altan","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026052108403430000_13.8.e012089.50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2469"},{"key":"2026052108403430000_13.8.e012089.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01201-8"},{"key":"2026052108403430000_13.8.e012089.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29175-x"},{"key":"2026052108403430000_13.8.e012089.53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2019.09.009","article-title":"Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer","volume":"48","author":"Svedlund","year":"2019","journal-title":"EBioMedicine"},{"key":"2026052108403430000_13.8.e012089.54","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26271-2","article-title":"Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions","volume":"12","author":"Andersson","year":"2021","journal-title":"Nat Commun"},{"key":"2026052108403430000_13.8.e012089.55","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-05425-2","article-title":"Spatial genomics maps the structure, nature and evolution of cancer clones","volume":"611","author":"Lomakin","year":"2022","journal-title":"Nature New Biol"},{"key":"2026052108403430000_13.8.e012089.56","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf8486","article-title":"Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics","volume":"382","author":"Engblom","year":"2023","journal-title":"Science"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:40:53Z","timestamp":1779378053000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,27]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/jitc-2025-012089"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012089","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}